S. Avigad

发表

Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

May D. Wang, Wenwei Zhang, Simon M Lin, 2015, Genome Biology.

Molecular cytogenetic parameters in Ewing sarcoma.

I. Yaniv, S. Avigad, A. Amiel, 2003, Cancer genetics and cytogenetics.

Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

Gary D Bader, David T. W. Jones, V. P. Collins, 2015, Cancer cell.

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Roland Eils, Gudrun Schleiermacher, Barbara Hero, 2014, Clinical Cancer Research.

Telomere length is a prognostic factor in neuroblastoma

M. Feinmesser, I. Yaniv, S. Avigad, 2006, Cancer.

Prognostic impact of gene expression-based classification for neuroblastoma.

Roland Eils, Lars Kaderali, Gudrun Schleiermacher, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome

G. Wainreb, A. Green, A. Borkhardt, 2008, The Lancet.

CCM2 Mediates Death Signaling by the TrkA Receptor Tyrosine Kinase

R. Eils, Leming Shi, M. Fischer, 2009, Neuron.

Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T‐cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real‐time quantitative polymerase chain reaction (RQ‐PCR)

I. Yaniv, S. Avigad, D. Luria, 2009, Pediatric blood & cancer.

Minimal residual disease (MRD) analysis in the non-MRD-based ALL IC-BFM 2002 protocol for childhood ALL: is it possible to avoid MRD testing?

E. Mejstrikova, O. Hrusak, E. Froňková, 2008, Leukemia.

Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma

I. Yaniv, S. Avigad, A. Ohali, 2008, Genes, chromosomes & cancer.

The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse

T. Rausch, J. Korbel, A. Stütz, 2014, Haematologica.

TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia

I. Yaniv, S. Avigad, R. Zaizov, 1999, Leukemia.

Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

T. Rausch, J. Korbel, M. Muckenthaler, 2022, Leukemia.

Mutations of JAK 2 in acute lymphoblastic leukaemias associated with Down ’ s syndrome

G. Wainreb, A. Green, A. Borkhardt, 2008 .

A novel germ line p53 mutation in intron 6 in diverse childhood malignancies

S. Avigad, I. Cohen, R. Zaizov, 1997, Oncogene.

Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma

R. Grimer, S. Avigad, E. Maher, 2013, Epigenetics.

p53 mutation as the second event in juvenile chronic myelogenous leukemia in a patient with neurofibromatosis type 1

S. Avigad, R. Weitz, I. Cohen, 1997, Cancer.

New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B‐cell precursor acute lymphoblastic leukaemia

R. Pieters, T. Révész, C. Eckert, 2016, British journal of haematology.

A single origin of phenylketonuria in Yemenite Jews

Y. Shiloh, M. Frydman, S. Avigad, 1990, Nature.

RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma

R. Grimer, S. Avigad, E. Maher, 2013, Epigenetics.

Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma

I. Yaniv, S. Shukla, S. Avigad, 2009, Pediatric blood & cancer.

Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

T. Rausch, J. Korbel, M. Muckenthaler, 2022, Leukemia.

Mutations of the adenomatous polyposis coli and p53 genes in a child with Turcot's syndrome.

S. Avigad, I. Cohen, R. Zaizov, 1998, Cancer letters.

A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family.

S. Avigad, I. Cohen, R. Zaizov, 1998, Cancer genetics and cytogenetics.

Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.

S. Avigad, I. Cohen, R. Zaizov, 1997, Leukemia research.

Compound heterozygosity in nonphenylketonuria hyperphenylalanemia: the contribution of mutations for classical phenylketonuria.

Y. Shiloh, S. Avigad, S. Kleiman, 1991, American journal of human genetics.

Excellent Prognosis in a Subset of Patients with Ewing Sarcoma Identified at Diagnosis by CD56 Using Flow Cytometry

H. Toledano, I. Yaniv, S. Avigad, 2011, Clinical Cancer Research.

Imaging , Diagnosis , Prognosis Excellent Prognosis in a Subset of Patients with Ewing Sarcoma Identified at Diagnosis by CD 56 Using Flow Cytometry

H. Toledano, I. Yaniv, S. Avigad, 2011 .

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

J. Cayuela, V. V. D. van der Velden, T. Lion, 2019, Leukemia.

Molecular analysis of childhood acute lymphoblastic leukemia in Israel.

S. Avigad, I. Cohen, R. Zaizov, 1998, Leukemia research.

A missense mutation, S349P, completely inactivates phenylalanine hydroxylase in North African Jews with phenylketonuria

A. Munnich, Y. Shiloh, S. Lyonnet, 1993, Human Genetics.

Origins of Hyperphenylalaninemia in Israel

A. Munnich, Y. Shiloh, S. Avigad, 1994, European journal of human genetics : EJHG.

Homozygous deletion of RAG1, RAG2 and 5′ region TRAF6 causes severe immune suppression and atypical osteopetrosis

A. Villa, I. Yaniv, S. Avigad, 2017, Clinical genetics.

Minimal Residual Disease in Peripheral Blood Stem Cell Harvests From High-risk Neuroblastoma Patients

I. Yaniv, S. Avigad, S. Ash, 2009, Journal of pediatric hematology/oncology.

Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma.

A. Tobar, S. Avigad, R. Zaizov, 2000, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Occasional involvement of the ovary in Ewing sarcoma.

M. Feinmesser, B. Fisch, I. Yaniv, 2010, Human reproduction.

Prediction of high-risk Ewing's sarcoma by gene expression profiling

R. Ophir, S. Horn-Saban, I. Yaniv, 2005, Oncogene.

Prediction of high risk Ewing's sarcoma by gene expression profiling

R. Ophir, S. Horn-Saban, I. Yaniv, 2004, Oncogene.

The Effect of Aloe Emodin on the Proliferation of a New Merkel Carcinoma Cell Line

S. Avigad, E. Fenig, E. Beery, 2002, The American Journal of dermatopathology.

Frequent and sex-biased deletion of SLX4IP by illegitimate V(D)J-mediated recombination in childhood acute lymphoblastic leukemia.

B. Meissner, I. Heřmanová, A. Teigler‐Schlegel, 2014, Human molecular genetics.

Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation

V. Beneš, T. Rausch, J. Korbel, 2015, Haematologica.

Risk Estimation and Treatment Strati fi cation of Low-and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

R. Eils, F. Westermann, F. Berthold, 2015 .

miR expression profiling at diagnosis predicts relapse in pediatric precursor B‐cell acute lymphoblastic leukemia

E. Froňková, I. Yaniv, J. Trka, 2016, Genes, chromosomes & cancer.

Prospective comparison of two flow cytometry methodologies for monitoring minimal residual disease in a multicenter treatment protocol of childhood acute lymphoblastic leukemia

D. Steinberg, N. Amariglio, S. Izraeli, 2010, Cytometry. Part B, Clinical cytometry.

Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells

I. Yaniv, S. Avigad, K. Shichrur, 2014, Pediatric Research.

Association between telomerase activity and outcome in patients with nonmetastatic Ewing family of tumors.

I. Yaniv, S. Avigad, J. Issakov, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.

I. Yaniv, S. Avigad, J. Kapelushnik, 2010, The American journal of pathology.

The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors

I. Yaniv, S. Avigad, J. Issakov, 2004, Cancer.

Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome

A. Tanay, B. Wagner, A. Borkhardt, 2017, Proceedings of the National Academy of Sciences.

A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with the variant t(8:19)(p11:q13)--case report and review of the literature.

S. Avigad, R. Zaizov, S. Ash, 1995, Leukemia research.

ATM gene mutations are not involved in medulloblastoma in children.

I. Yaniv, S. Avigad, I. Cohen, 2003, Cancer genetics and cytogenetics.

SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS

M. Feinmesser, H. Toledano, S. Avigad, 2019, Cancer Chemotherapy and Pharmacology.

Short Telomeres: A Novel Potential Predictor of Relapse in Ewing Sarcoma

I. Yaniv, S. Avigad, J. Issakov, 2007, Clinical Cancer Research.

p73 Overexpression and Nuclear Accumulation in Hepatitis C Virus-Associated Hepatocellular Carcinoma

Y. Shaul, S. Avigad, R. Tur-kaspa, 2002, Digestive Diseases and Sciences.

Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation

M. Feinmesser, I. Yaniv, S. Avigad, 2007, Bone Marrow Transplantation.

Tumor cells are present in stem cell harvests of Ewings sarcoma patients and their persistence following transplantation is associated with relapse

I. Yaniv, S. Avigad, I. Cohen, 2004, Pediatric blood & cancer.

Prenatal Diagnosis in Li-Fraumeni Syndrome

I. Yaniv, S. Avigad, M. Shohat, 2004, Journal of pediatric hematology/oncology.

Poorer outcome of childhood acute lymphoblastic leukemia in the Bedouin population: A report from the Berlin‐Frankfurt‐Muenster–based Israeli national protocols

R. Elhasid, S. Izraeli, A. Toren, 2020, Pediatric blood & cancer.

High frequency of loss of heterozygosity for 1p35-p36 (D1S247) in Wilms tumor.

S. Avigad, R. Zaizov, S. Ash, 2000, Cancer genetics and cytogenetics.

Association B etween T elomerase A ctivity a nd O utcome i n Patients W ith N onmetastatic E wing F amily o f T umors

I. Yaniv, S. Avigad, J. Issakov, 2013 .

Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.

H. Toledano, I. Yaniv, S. Avigad, 2017, Journal of pediatric surgery.

Prognostic relevance of miR‐124‐3p and its target TP53INP1 in pediatric ependymoma

S. Pfister, C. Hawkins, M. Feinmesser, 2017, Genes, chromosomes & cancer.

Synovial sarcoma of bone delineated by spectral karyotyping

Irit Bar-Am, I. Bar-Am, S. Avigad, 1997, The Lancet.

Deferasirox induces cyclin D1 degradation and apoptosis in mantle cell lymphoma in a reactive oxygen species‐ and GSK3β‐dependent mechanism

S. Avigad, O. Shpilberg, P. Raanani, 2021, British journal of haematology.

Molecular variants of the ATM gene in Hodgkin's disease in children

I. Yaniv, S. Avigad, R. Zaizov, 2004, British Journal of Cancer.

Germ‐line ATM gene alterations are associated with susceptibility to sporadic T‐cell acute lymphoblastic leukemia in children

M. Gorfine, I. Yaniv, S. Avigad, 2004, Genes, chromosomes & cancer.

miR-192 Directly Binds and Regulates Dicer1 Expression in Neuroblastoma

Abraham Weizman, N. Shomron, M. Feinmesser, 2013, PloS one.

Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.

J. Sulkes, S. Avigad, H. Schmilovitz-Weiss, 2006, Cancer detection and prevention.

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MRD-ALL Consortia

E. Yeoh, J. Cayuela, B. Schäfer, 2011 .

Reduced levels of miR‐34a in neuroblastoma are not caused by mutations in the TP53 binding site

Abraham Weizman, I. Yaniv, S. Avigad, 2009, Genes, chromosomes & cancer.

High frequency of genomic instability in Ewing family of tumors.

I. Yaniv, S. Avigad, J. Issakov, 2004, Cancer genetics and cytogenetics.

Improved Outcome in Local Ewing Sarcoma With an Intensified Pilot Treatment Protocol SCMCIE 94

H. Toledano, I. Yaniv, S. Avigad, 2019, Journal of pediatric hematology/oncology.

Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma.

Y. Tamir, I. Yaniv, S. Avigad, 1997, European journal of cancer.

The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth

Abraham Weizman, M. Feinmesser, Y. Kloog, 2015, Oncotarget.

Novel approaches for the management of patients with Ewing sarcoma.

I. Yaniv, S. Avigad, 2006, Future oncology.

PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro.

D. Esposito, M. Quon, I. Yaniv, 2002, The Journal of clinical endocrinology and metabolism.

Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis.

S. Avigad, I. Cohen, B. Stark, 2000, Medical and pediatric oncology.

The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse

T. Rausch, J. Korbel, A. Stütz, 2014, Haematologica.

Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma

I. Yaniv, S. Avigad, A. Ohali, 2008, Genes, chromosomes & cancer.

J. Cayuela, S. Schnittger, J. Dongen, 2019, Leukemia.

M. Feinmesser, H. Toledano, S. Avigad, 2019, Cancer Chemotherapy and Pharmacology.